Why the study?
Soluble ST2 has emerged as a promising prognostic biomarker, prompting the development of practical sST2-assisted clinical flowcharts for risk stratification and management in the emergency department.
Does soluble ST2 (sST2) measurement improve risk stratification in patients with acute heart failure and acute coronary syndrome in the emergency department?
Design
Review
Authors
Loading...
sST2 may aid risk stratification in acute CV disease; leaves open prospective validation before routine use.
Does soluble ST2 (sST2) measurement improve risk stratification in patients with acute heart failure and acute coronary syndrome in the emergency department?
Soluble ST2 can be integrated into clinical flowcharts to assist emergency physicians in the risk stratification of patients with acute heart failure and acute myocardial infarction.
Aleksova et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: